Skip to main content

Table 3 Insulin regimen at initiation and at 1-year follow-up

From: Baseline and 1-year interim follow-up assessment of Japanese patients initiating insulin therapy who were enrolled in the cardiovascular risk evaluation in people with type 2 diabetes on insulin therapy study: an international, multicenter, observational study

Insulin regimen At insulin initiation (N = 511) 1-year follow-up (N = 488)
N (%) Mean dose ± SD (Unit) N (%) Mean dose ± SD (Unit)
Basal 32 (6.3%) 7.2 ± 2.9 35 (7.2%) 11.0 ± 4.5
Basal + short-acting 134 (26.2%) Basal: 5.0 ± 2.5 Short: 14.9 ± 6.9 84 (17.2%) Basal: 10.2 ± 8.4 Short: 19.4 ± 8.0
Short-acting 130 (25.4%) 12.8 ± 8.0 54 (11.1%) 17.6 ± 10.3
Premix 188 (36.8%) 12.3 ± 7.3 230 (47.1%) 20.4 ± 11.5
Others 27 (5.3%) - 58 (11.9%) -
No insulin 0 - 27 (5.5%) -